Clinical Trials Directory

Trials / Completed

CompletedNCT05608824

Evaluation of Lower Extremity Athletic Injuries and Response to Treatment Using SWE and MFI

Evaluation of Lower Extremity Athletic Injuries and Response to Treatment Using Shear Wave Elastography and Micro-vascular Flow Imaging

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
9 (actual)
Sponsor
Oregon Health and Science University · Academic / Other
Sex
All
Age
18 Years – 89 Years
Healthy volunteers
Not accepted

Summary

Primary Objective: To explore changes in shear wave elastography (SWE) and microvascular flow imaging (MFI) measurements from time of injury through the recovery phase of lower extremity musculoskeletal injuries to determine if a correlation exists with functional impairment. Secondary Objective: To develop a deep learning AI system for automated region of interest (ROI) determination for measurement of average SWE and MFI. Methodology: Eligible subjects with lower extremity injuries will undergo SWE and MFI measurements and complete the Lower Extremity Functional Scale questionnaire at each study visit. Clinical data related to the evaluation of the injury acquired during standard medical care of the injury will be collected from the patients' medical record such as CT or MRI scans, X-rays, physical exams and tests as well as laboratory measurements. Subjects will undergo serial SWE and MFI imaging throughout their rehabilitation episode of care to assess changes over time, status in rehabilitation and comparison to the contralateral extremity.

Conditions

Interventions

TypeNameDescription
DEVICEShear wave elastography and microvascular flow imaging.Subjects will undergo serial SWE and MFI imaging throughout their rehabilitation episode of care to assess changes over time, status in rehabilitation and comparison to the contralateral extremity.

Timeline

Start date
2023-10-01
Primary completion
2025-02-28
Completion
2025-09-30
First posted
2022-11-08
Last updated
2026-04-07

Locations

2 sites across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT05608824. Inclusion in this directory is not an endorsement.